The 2014 annual report highlights gains in malaria treatment, eye care missions, and tree planting. Novartis also strengthened its ethics and reporting to better track its social and environmental impact.
Inspired by her grandmother, Dr. Parisa Zamiri now researches treatments for macular degeneration. She uses her expertise in translational medicine to find ways to slow vision loss in patients.
Novartis is proud to have achieved Silver Class status in this year's edition of the RobecoSAM "Sustainability Yearbook" for our excellent sustainability performance.
